Floch F, Boissy L, Lanore D, Sayag D, Serres F
The peptide gained Health Canada and FDA approval for HIV-associated lipodystrophy, establishing a safety and efficacy profile through rigorous clinical evaluation
Chambrier C, Laville M, Rhzioual Berrada K, Odeon M, Boultreau P, Beylot M
In vivo experiments have validated Onenas approach, proving that disruption of a DSIPs activity with a neutralizing antibody reprograms cancer cells to accept environmental cell death signals from BMPs and Activins
It was the best experience I've had with any IV and I will be booking again
Wraparound support New therapies for weight loss mean more choice for patients, eventually resulting in lower prices and more personalised approaches